Literature DB >> 23499446

Inhibition of mitochondrial aconitase by succination in fumarate hydratase deficiency.

Nicola Ternette1, Ming Yang, Mahima Laroyia, Mitsuhiro Kitagawa, Linda O'Flaherty, Kathryn Wolhulter, Kaori Igarashi, Kaori Saito, Keiko Kato, Roman Fischer, Alexandre Berquand, Benedikt M Kessler, Terry Lappin, Norma Frizzell, Tomoyoshi Soga, Julie Adam, Patrick J Pollard.   

Abstract

The gene encoding the Krebs cycle enzyme fumarate hydratase (FH) is mutated in hereditary leiomyomatosis and renal cell cancer (HLRCC). Loss of FH activity causes accumulation of intracellular fumarate, which can directly modify cysteine residues to form 2-succinocysteine through succination. We undertook a proteomic-based screen in cells and renal cysts from Fh1 (murine FH)-deficient mice and identified 94 protein succination targets. Notably, we identified the succination of three cysteine residues in mitochondrial Aconitase2 (ACO2) crucial for iron-sulfur cluster binding. We show that fumarate exerts a dose-dependent inhibition of ACO2 activity, which correlates with increased succination as determined by mass spectrometry, possibly by interfering with iron chelation. Importantly, we show that aconitase activity is impaired in FH-deficient cells. Our data provide evidence that succination, resulting from FH deficiency, targets and potentially alters the function of multiple proteins and may contribute to the dysregulated metabolism observed in HLRCC.
Copyright © 2013 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23499446      PMCID: PMC3617368          DOI: 10.1016/j.celrep.2013.02.013

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  40 in total

1.  The mechanism of aconitase: 1.8 A resolution crystal structure of the S642a:citrate complex.

Authors:  S J Lloyd; H Lauble; G S Prasad; C D Stout
Journal:  Protein Sci       Date:  1999-12       Impact factor: 6.725

2.  Probability-based protein identification by searching sequence databases using mass spectrometry data.

Authors:  D N Perkins; D J Pappin; D M Creasy; J S Cottrell
Journal:  Electrophoresis       Date:  1999-12       Impact factor: 3.535

3.  Aberrant succination of proteins in fumarate hydratase-deficient mice and HLRCC patients is a robust biomarker of mutation status.

Authors:  Chiara Bardella; Mona El-Bahrawy; Norma Frizzell; Julie Adam; Nicola Ternette; Emine Hatipoglu; Kimberley Howarth; Linda O'Flaherty; Ian Roberts; Gareth Turner; Jennifer Taylor; Konstantinos Giaslakiotis; Valentine M Macaulay; Adrian L Harris; Ashish Chandra; Heli J Lehtonen; Virpi Launonen; Lauri A Aaltonen; Christopher W Pugh; Radu Mihai; David Trudgian; Benedikt Kessler; John W Baynes; Peter J Ratcliffe; Ian P Tomlinson; Patrick J Pollard
Journal:  J Pathol       Date:  2011-06-01       Impact factor: 7.996

Review 4.  Succination of proteins in diabetes.

Authors:  Norma Frizzell; Maria Lima; John W Baynes
Journal:  Free Radic Res       Date:  2010-10-22

5.  Differential metabolomics reveals ophthalmic acid as an oxidative stress biomarker indicating hepatic glutathione consumption.

Authors:  Tomoyoshi Soga; Richard Baran; Makoto Suematsu; Yuki Ueno; Satsuki Ikeda; Tadayuki Sakurakawa; Yuji Kakazu; Takamasa Ishikawa; Martin Robert; Takaaki Nishioka; Masaru Tomita
Journal:  J Biol Chem       Date:  2006-04-11       Impact factor: 5.157

6.  Succination of protein thiols during adipocyte maturation: a biomarker of mitochondrial stress.

Authors:  Ryoji Nagai; Jonathan W Brock; Matthew Blatnik; John E Baatz; Jennifer Bethard; Michael D Walla; Suzanne R Thorpe; John W Baynes; Norma Frizzell
Journal:  J Biol Chem       Date:  2007-08-28       Impact factor: 5.157

7.  Characterization of the human mitochondrial aconitase gene (ACO2).

Authors:  D B Mirel; K Marder; J Graziano; G Freyer; Q Zhao; R Mayeux; K C Wilhelmsen
Journal:  Gene       Date:  1998-06-15       Impact factor: 3.688

Review 8.  Hallmarks of cancer: the next generation.

Authors:  Douglas Hanahan; Robert A Weinberg
Journal:  Cell       Date:  2011-03-04       Impact factor: 41.582

9.  Reductive carboxylation supports growth in tumour cells with defective mitochondria.

Authors:  Andrew R Mullen; William W Wheaton; Eunsook S Jin; Pei-Hsuan Chen; Lucas B Sullivan; Tzuling Cheng; Youfeng Yang; W Marston Linehan; Navdeep S Chandel; Ralph J DeBerardinis
Journal:  Nature       Date:  2011-11-20       Impact factor: 69.504

10.  Metabolic enzymes as oncogenes or tumor suppressors.

Authors:  Craig B Thompson
Journal:  N Engl J Med       Date:  2009-02-19       Impact factor: 176.079

View more
  67 in total

1.  Exploiting tumor metabolism: challenges for clinical translation.

Authors:  Matthew G Vander Heiden
Journal:  J Clin Invest       Date:  2013-09-03       Impact factor: 14.808

2.  Oxidation of alpha-ketoglutarate is required for reductive carboxylation in cancer cells with mitochondrial defects.

Authors:  Andrew R Mullen; Zeping Hu; Xiaolei Shi; Lei Jiang; Lindsey K Boroughs; Zoltan Kovacs; Richard Boriack; Dinesh Rakheja; Lucas B Sullivan; W Marston Linehan; Navdeep S Chandel; Ralph J DeBerardinis
Journal:  Cell Rep       Date:  2014-05-22       Impact factor: 9.423

3.  Identification of a metabolic disposal route for the oncometabolite S-(2-succino)cysteine in Bacillus subtilis.

Authors:  Thomas D Niehaus; Jacob Folz; Donald R McCarty; Arthur J L Cooper; David Moraga Amador; Oliver Fiehn; Andrew D Hanson
Journal:  J Biol Chem       Date:  2018-04-06       Impact factor: 5.157

4.  Mitochondrial DNA alterations underlie an irreversible shift to aerobic glycolysis in fumarate hydratase-deficient renal cancer.

Authors:  Daniel R Crooks; Nunziata Maio; Martin Lang; Christopher J Ricketts; Cathy D Vocke; Sandeep Gurram; Sevilay Turan; Yun-Young Kim; G Mariah Cawthon; Ferri Sohelian; Natalia De Val; Ruth M Pfeiffer; Parthav Jailwala; Mayank Tandon; Bao Tran; Teresa W-M Fan; Andrew N Lane; Thomas Ried; Darawalee Wangsa; Ashkan A Malayeri; Maria J Merino; Youfeng Yang; Jordan L Meier; Mark W Ball; Tracey A Rouault; Ramaprasad Srinivasan; W Marston Linehan
Journal:  Sci Signal       Date:  2021-01-05       Impact factor: 8.192

Review 5.  The succinated proteome.

Authors:  Eric D Merkley; Thomas O Metz; Richard D Smith; John W Baynes; Norma Frizzell
Journal:  Mass Spectrom Rev       Date:  2013-09-30       Impact factor: 10.946

6.  Identification of protein succination as a novel modification of tubulin.

Authors:  Gerardo G Piroli; Allison M Manuel; Michael D Walla; Matthew J Jepson; Jonathan W C Brock; Mathur P Rajesh; Ross M Tanis; William E Cotham; Norma Frizzell
Journal:  Biochem J       Date:  2014-09-01       Impact factor: 3.857

7.  Mild mitochondrial metabolic deficits by α-ketoglutarate dehydrogenase inhibition cause prominent changes in intracellular autophagic signaling: Potential role in the pathobiology of Alzheimer's disease.

Authors:  Kalpita Banerjee; Soumyabrata Munshi; Hui Xu; David E Frank; Huan-Lian Chen; Charleen T Chu; Jiwon Yang; Sunghee Cho; Valerian E Kagan; Travis T Denton; Yulia Y Tyurina; Jian Fei Jiang; Gary E Gibson
Journal:  Neurochem Int       Date:  2016-02-23       Impact factor: 3.921

8.  Hereditary leiomyomatosis and renal cell carcinoma syndrome-associated renal cancer: recognition of the syndrome by pathologic features and the utility of detecting aberrant succination by immunohistochemistry.

Authors:  Ying-Bei Chen; A Rose Brannon; Antoun Toubaji; Maria E Dudas; Helen H Won; Hikmat A Al-Ahmadie; Samson W Fine; Anuradha Gopalan; Norma Frizzell; Martin H Voss; Paul Russo; Michael F Berger; Satish K Tickoo; Victor E Reuter
Journal:  Am J Surg Pathol       Date:  2014-05       Impact factor: 6.394

Review 9.  Molecular Pathogenesis and Diagnostic, Prognostic and Predictive Molecular Markers in Sarcoma.

Authors:  Adrián Mariño-Enríquez; Judith V M G Bovée
Journal:  Surg Pathol Clin       Date:  2016-09

Review 10.  Redox Signaling by Reactive Electrophiles and Oxidants.

Authors:  Saba Parvez; Marcus J C Long; Jesse R Poganik; Yimon Aye
Journal:  Chem Rev       Date:  2018-08-27       Impact factor: 60.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.